Literature DB >> 11376338

Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines.

G Cinamon1, V Shinder, R Alon.   

Abstract

Leukocyte transendothelial migration (TEM) is thought to be a chemotactic process controlled by chemokine gradients across the endothelium. Using cytokine-activated human umbilical vascular endothelial cells (HUVECs) as a model of inflamed endothelium, we have shown that apical endothelial chemokines can trigger robust peripheral blood lymphocyte (PBL) migration across endothelial cells. Lymphocyte TEM was promoted by physiological shear stress applied continuously to migrating lymphocytes. Lymphocyte integrins, intact actin cytoskeleton and G(i) protein-mediated chemokine signaling, but not a chemotactic gradient, were mandatory for TEM. PBL TEM did not require intracellular free calcium or intact phosphatidyl inositol kinase activity in migrating lymphocytes. Thus, lymphocyte TEM is promoted by fluid shear-induced mechanical signals coupled to G(i) protein signals at apical endothelial zones.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376338     DOI: 10.1038/88710

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  107 in total

1.  Pseudopod projection and cell spreading of passive leukocytes in response to fluid shear stress.

Authors:  Mark F Coughlin; Geert W Schmid-Schönbein
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

2.  Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots.

Authors:  Ziv Shulman; Shmuel J Cohen; Ben Roediger; Vyacheslav Kalchenko; Rohit Jain; Valentin Grabovsky; Eugenia Klein; Vera Shinder; Liat Stoler-Barak; Sara W Feigelson; Tsipi Meshel; Susanna M Nurmi; Itamar Goldstein; Olivier Hartley; Carl G Gahmberg; Amos Etzioni; Wolfgang Weninger; Adit Ben-Baruch; Ronen Alon
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

3.  Cancer cells regulate biomechanical properties of human microvascular endothelial cells.

Authors:  Claudia Tanja Mierke
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

4.  Intravital 2-photon imaging of leukocyte trafficking in beating heart.

Authors:  Wenjun Li; Ruben G Nava; Alejandro C Bribriesco; Bernd H Zinselmeyer; Jessica H Spahn; Andrew E Gelman; Alexander S Krupnick; Mark J Miller; Daniel Kreisel
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

5.  Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.

Authors:  Oliver Steiner; Caroline Coisne; Britta Engelhardt; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-07       Impact factor: 6.200

6.  CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.

Authors:  Shumei Man; Barbara Tucky; Anne Cotleur; Judith Drazba; Yukio Takeshita; Richard M Ransohoff
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

Review 7.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 8.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

9.  A flow adhesion assay to study leucocyte recruitment to human hepatic sinusoidal endothelium under conditions of shear stress.

Authors:  Shishir Shetty; Christopher J Weston; David H Adams; Patricia F Lalor
Journal:  J Vis Exp       Date:  2014-03-21       Impact factor: 1.355

Review 10.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.